Estimating the risks and benefits of tamoxifen for prophylactic breast cancer chemoprevention in Korea
{{output}}
Purpose: According to the National Surgical Adjuvant Breast and Bowel Project P1 (NSABP-P1) study, tamoxifen can prevent 49% of invasive breast cancers in patients who have a 5-year risk of 1.67% or more. Because tamoxifen is ass... ...
